IFNG and COVID-19: It has been observed that, while the Ad26.COV2.S (Janssen COVID-19 Vaccine)might indeed provoke an early IFN-γ response, the fact that there may be a need for booster doses underscores one of the most important aspects of ongoing vaccine strategies as related to this vulnerable population (24).